MedTrace Logo

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

NCT05426720 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-06-22

No results posted yet for this study

Summary

This prospective study aims to determine the incidence of Post-tuberculosis lung damage (PTLD), examine trends in the changes in lung function, and investigate the impact of smoking and other factors on respiratory symptoms, lung function, and chest CT findings, which will aid in the development of prognostic and therapeutic strategies for PTLD.

Conditions

  • Pulmonary TB

Interventions

OTHER

no intervention

no intervention; This study is a observational study. All patients received routine anti-tuberculosis regimen. Researchers will observe the clinical manifestation, pulmonary function and pulmonary CT manifestation within a few years after the cure of tuberculosis.

Sponsors & Collaborators

  • Beijing Geriatric Hospital

    collaborator OTHER

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Yongchang Sun, MD · Respiratory and Critical Care Department, Peking University Third Hospital

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05426720 on ClinicalTrials.gov